MONITILLO, LUIGIA

MONITILLO, LUIGIA  

Mostra records
Risultati 1 - 20 di 30 (tempo di esecuzione: 0.043 secondi).
Titolo Data di pubblicazione Autore(i) File
A COMPARATIVE ANALYSIS OF NEXT GENERATION SEQUENCING AND REAL TIME QUANTITATIVE–PCR FOR MINIMAL RESIDUAL DEECTION IN FOLLICULAR LYMPHOMA 2013 Pott C; Monitillo L; Genuardi E; et al
Cells carrying nonlymphoma-associated bcl-2/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populations 2006 LADETTO M; MANTOAN B; DE MARCO F; DRANDI D; AGUZZI C; ASTOLFI M; VALLET S; RICCA I; AQUILA MD; PAGLIANO G; MONITILLO L; POLLIO B; SANTO L; CRISTIANO C; ROCCI A; FRANCESE R; BODONI CL; BORCHIELLINI A; SCHINCO P; BOCCADORO M; TARELLA C
Comparison of different DNA extraction methods from peripheral blood cells: advices from the Fondazione Italiana Linfomi - MRD Network. 2016 Mannu C;Gazzola A;Ciabatti E;Fuligni F;Cavalli M;Della Starza I;Genuardi E;Mantoan B;Monitillo L;Del Giudice I;Ladetto M;Gaidano G;Sabattini E;Pileri SA;Galimberti S;Piccaluga PP;on behalf of Fondazione Italiana Linfomi - MrdNetwork
COMPARISON OF DIFFERENT RQ-PCR DESIGN STRATEGIES FOR MINIMAL RESIDUAL DISEASE DETECTION IN LYMPHOPROLIFERATIVE DISORDERS: CORRELATION BETWEEN IMMUNOGLOBULIN GENE MUTATION LOAD AND RQ-PCR PERFORMANCE 2013 Della Starza I.; Cavalli M.; Del Giudice I.; Monitillo L
Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performance. 2014 Della Starza I; Cavalli M; Del Giudice I; Barbero D; Mantoan B; Genuardi E; Urbano M; Mannu C; Gazzola A; Ciabatti E; Guarini A; Foà R; Galimberti S; Piccaluga P; Gaidano G; Ladetto M; Monitillo L.
Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome 2005 Ladetto M; Vallet S; Trojan A; Dell'aquila M; Monitillo L; Rosato R; Santo L; Drandi D; Bertola A; Falco P; Cavallo F; Ricca I; De Marco F; Mantoan B; Bode-Lesniewska B; Pagliano G; Francese R; Rocci A; Astolfi M; Compagno M; Mariani S; Godio L; Marino L; Ruggeri M; Omede P; Palumbo A; Boccadoro M
Expression of telomeric proteins in chronic lymphocytic leukemia (CLL) 2011 Barbero D; Drandi D; Lobetti Bodoni C; Bernocco E; Coscia M; Ruggeri M; Boi M; Genuardi E; Monitillo L; Mantoan B; Maffeo C; Barbiero S; Ferrero S; Rossi D; Passera R; Gaidano G; Massaia M; Omedè P; Boccadoro M; Ladetto M
Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis 2018 Genuardi, E.; Barbero, D.; Dogliotti, I.; Mantoan, B.; Drandi, D.; Gambella, M.; Zaccaria, G.M.; Monitillo, L.; Della Starza, I.; Cavalli, M.; De Novi, L.A.; Ciabatti, E.; Grassi, S.; Gazzola, A.; Mannu, C.; Del Giudice, I.; Galimberti, S.; Agostinelli, C.; Piccaluga, P.P.; Ladetto, M.; Ferrero, S.*
HashClone: a new tool to quantify the minimal residual disease in B-cell lymphoma from deep sequencing data 2017 Beccuti, Marco; Genuardi, Elisa; Romano, Greta; Monitillo, Luigia; Barbero, Daniela; Boccadoro, Mario; Ladetto, Marco; Calogero, Raffaele Adolfo; Ferrero, Simone; Cordero, Francesca
HIGH RATES OF PROLONGED MOLECULAR REMISSIONS AFTER TANDEM AUTOLOGOUS-NONMYELOABLATIVE ALLOGRAFTING IN NEWLY DIAGNOSED MYELOMA 2013 Ladetto M, Ferrero S, Drandi D,; Festuccia M.; Patriarca F.; Mordini N.; Cena S.; Barbero D.; Monitillo L.
High Rates of Prolonged Molecular Remissions After Tandem Autologous-Nonmyeloablative Allografting in Newly Diagnosed Myeloma 2013 Benedetto Bruno; Simone Ferrero; Daniela Drandi ; Moreno Festuccia; Francesca Patriarca; Nicola Mordini; Silvia Cena; Luigia Monitillo; Luisa Giaccone; Federica Ferrando; Daniela Barbero; Alberto Rocci; Sara Barbiero; Andrea Gallamini; Renato Fanin; Roberto Passera; Antonio Palumbo; Mario Boccadoro; Paola Omedè; Marco Ladetto
High Rates of Prolonged Molecular Remissions After Tandem Autologous-Nonmyeloablative Allografting in Newly Diagnosed Myeloma 2013 Benedetto Bruno; Simone Ferrero; Daniela Drandi; Moreno Festuccia; Francesca Patriarca; Nicola Mordini; Silvia Cena; Daniela Barbero; Luigia Monitillo; Luisa Giaccone; Sara Barbiero; Andrea Gallamini3; Renato Fanin; Roberto Passera; Antonio Palumbo; Mario Boccadoro; Paola Omedè and Marco Ladetto
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma 2020 Della Starza I.; De Novi L.A.; Cavalli M.; Novelli N.; Soscia R.; Genuardi E.; Mantoan B.; Drandi D.; Ferrante M.; Monitillo L.; Barbero D.; Ciabatti E.; Grassi S.; Bomben R.; Degan M.; Gattei V.; Galimberti S.; Di Rocco A.; Martelli M.; Cortelazzo S.; Guarini A.; Foa R.; Ladetto M.; Ferrero S.; Del Giudice I.
LONG-TERM RESULTS of the GIMEMA VTD Consolidation TRIAL In Autografted MULTIPLE Myeloma PATIENTS (VEL-03-096): IMPACT of Minimal RESIDUAL DISEASE Detection by REAL Time Quantitative PCR On LATE Recurrences and Overall SURVIVAL 2011 Ladetto M.; Ferrero S.; Drandi D.; Cavallo F.; Monitillo L.; et al.
MINIMAL RESIDUAL DISEASE (MRD) DETECTION BY NEXT GENERATION SEQUENCING AND REAL TIME QUANTITATIVE–PCR: A METHODICAL COMPARISON IN ALL, MCL AND MM 2013 Ladetto M.; Bruggeman M; Monitillo L.
Minimal Residual Disease after Conventional Treatment Significantly Impacts on Progression-Free Survival of Patients with Follicular Lymphoma: The FIL FOLL05 Trial 2014 S. Galimberti;S. Luminari;E. Ciabatti;S. Grassi;F. Guerrini;A. Dondi;L. Marcheselli;M. Ladetto;P. P. Piccaluga;A. Gazzola;C. Mannu;L. Monitillo;B. Mantoan;I. Del Giudice;I. Della Starza;M. Cavalli;L. Arcaini;A. Tucci;G. A. Palumbo;L. Rigacci;A. Pulsoni;U. Vitolo;C. Boccomini;D. Vallisa;G. Bertoldero;G. Gaidano;P. Musto;M. Petrini;M. Federico
Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR 2015 Drandi, Daniela; Kubiczkova-Besse, Lenka; Ferrero, Simone; Dani, Nadia; Passera, Roberto; Mantoan, Barbara; Gambella, Manuela; Monitillo, Luigia; Saraci, Elona; Ghione, Paola; Genuardi, Elisa; Barbero, Daniela; Omedè, Paola; Barberio, Davide; Hajek, Roman; Vitolo, Umberto; Palumbo, Antonio; Cortelazzo, Sergio; Boccadoro, Mario; Inghirami, Giorgio; Ladetto, Marco
Molecular evaluation of Minimal Residual Disease and clinical impact analysis in the phase III study FIL MCL0208 2018 -
Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders 2014 Ladetto M; Brüggemann M; Monitillo L; Ferrero S; Pepin F; Drandi D; Barbero D; Palumbo A; Passera R; Boccadoro M; Ritgen M; Gökbuget N; Zheng J; Carlton V; Trautmann H; Faham M; Pott C.
Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans 2006 NOVO E; MARRA F; ZAMARA E; VALFRE DI BONZO L; MONITILLO L; CANNITO S; PETRAI I; MAZZOCCA A; BONACCHI A; DE FRANCO RS; COLOMBATTO S; AUTELLI R; PINZANI M; PAROLA M